Association between overuse of short-acting β2-agonists and the risk of major adverse cardiovascular events among patients with asthma
People with asthma who overuse rescue inhalers face significantly higher heart attack and death risks, underscoring the importance of proper inhaler technique and monitoring.
In a nationwide cohort of 231,970 asthma patients, overuse of short-acting beta-2 agonists was independently associated with a 25% increased risk of major adverse cardiovascular events, a 28% increased MI risk, and a 40% increased mortality risk compared to appropriate use. A clear dose-response relationship was observed, with MACE risk peaking at 6-8 canisters per year, underscoring the need for cardiovascular risk assessment in SABA-overusing asthma patients.
What the study was
- Study design
- Retrospective cohort study with IPTW propensity weighting
- Population
- Asthma patients in Taiwan (pay-for-performance database, 2011-2019)
- Sample size
- 231970
- Category
- Public Health
- Maturity
- Validated
- Journal
- Thorax
Why it surfaced
Largest study to date (n=231,970) demonstrating dose-dependent SABA overuse → MACE relationship with propensity adjustment; finding is directly actionable for asthma management guidelines and cardiovascular risk monitoring protocols.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.